Executive record

Amy M. Wendell

Director at Hologic, Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:amy-m-wendellVersion: public-0As of: 2026-09-29

Not yet claimed9 published Claims4 sources
  • Director

Key Claims

Biography

Amy M. Wendell served as Senior Vice President, Strategy & Business Development & Licensing at Covidien plc and has been a Hologic director since 2016. She was appointed Lead Independent Director in March 2024 and chairs the Nominating and Corporate Governance Committee. She brings deep expertise in strategy and business development in the medical technology sector.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Hologic, Inc.

Current

Claims

Conflicts and accountability

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

4 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. HOLX DEF 14A director slate

    sec filing · Source published: Jan 16, 2025 · Retrieved: May 9, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 9, 2026
    • Board role: Board role: Lead Independent Director · Claim reviewed: May 9, 2026
    • Committee assignments: Committee assignments: Compensation, Nominating/Governance · Claim reviewed: May 9, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 9, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 9, 2026

  2. Hologic, Inc. director board source

    sec filing · Source published: Jan 16, 2025 · Retrieved: May 3, 2026

    Supports 3 claims
    • Board independence: Independent director · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of Hologic, Inc. · Claim reviewed: May 3, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 3, 2026

  3. Open source

    sec proxy · Source published: Jan 16, 2025 · Retrieved: Mar 25, 2026

    Supports 1 claim
    • Professional Role: Director at Hologic, Inc. · Claim reviewed: May 9, 2026

  4. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Hologic, Inc. · Claim reviewed: May 3, 2026